Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;

Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease Eda Kaya; Eduardo Vilar-Gomez; Raj Vuppalanchi; Yusuf Yilmaz;

Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records Ignat Drozdov; Benjamin Szubert; Ian A. Rowe; Timothy J. Kendall; Jonathan A. Fallowfield;